These results suggest that, similar to NANOG, elevated MYC or SOCS2 expression in melanoma cells could shape the TME into expressing an immune-refractory feature, such as insufficient T cell trafficking to tumors and resistance of tumor cells to T cell–mediated killing. Here, NANOG is linked to melanoma.